| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967990 | Vaccine | 2012 | 4 Pages |
Abstract
⺠We explore the immunity against B:14:P1.7,16 before and after the MenBvac campaign. ⺠Children (1-5 years) from a district in Normandy were sampled ⺠Seroprotection was defined by human Serum Bactericidal Activity titer â¥4. ⺠The long term effect of the 2 + 1 schedule might be lower than expected. ⺠A 3 + 1 MenBvac schedule is preferable.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
François Caron, Valérie Delbos, Estelle Houivet, Ala-Eddine Deghmane, Jean-Philippe Leroy, Eva Hong, Jacques Bénichou, Muhamed-Kheir Taha,